SUMO-modifying Huntington’s disease-Reference-Cited by-同舟云学术

SUMO-modifying Huntington’s disease

Published:2022-06 Issue: Volume:12 Page:203-209
ISSN:2667-2421
Container-title:IBRO Neuroscience Reports
language:en
Short-container-title:IBRO Neuroscience Reports

Author:

Soares Ericks S.,Prediger Rui D.,Brocardo Patricia S.,Cimarosti Helena I.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference80 articles.

1. SUMOylation: implications for neurodegenerative diseases;Anderson,2017

2. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death;Arrasate;Nature,2004

3. Huntingtin and the synapse;Barron;Front. Cell. Neurosci.,2021

4. Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington’s disease therapy;Carbo;Int. J. Mol. Med.,2019

5. Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts;Celen;FEBS J.,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SUMOylation effects on neural stem cells self-renewal, differentiation, and survival;Neuroscience Research;2024-02

2. Triaging between post-translational modification of cell cycle regulators and their therapeutics in neurodegenerative diseases;Ageing Research Reviews;2024-02

3. Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration;Biomolecules;2024-01-16

4. SUMOylation Modulates Reactive Oxygen Species (ROS) Levels and Acts as a Protective Mechanism in the Type 2 Model of Diabetic Peripheral Neuropathy;Cells;2023-10-24

5. Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications;MedComm;2023-05-02